Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Complete Summary

GUIDELINE TITLE

Mastitis.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

Academy of Breastfeeding Medicine protocols expire five years from the date of publication. Evidence-based revisions are made within five years or sooner if there are significant changes in evidence.

COMPLETE SUMMARY CONTENT

 
SCOPE
 METHODOLOGY - including Rating Scheme and Cost Analysis
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS
 QUALIFYING STATEMENTS
 IMPLEMENTATION OF THE GUIDELINE
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

SCOPE

DISEASE/CONDITION(S)

Mastitis

GUIDELINE CATEGORY

Counseling
Diagnosis
Evaluation
Management
Prevention
Treatment

CLINICAL SPECIALTY

Family Practice
Infectious Diseases
Nursing
Nutrition
Obstetrics and Gynecology
Pediatrics

INTENDED USERS

Advanced Practice Nurses
Allied Health Personnel
Dietitians
Nurses
Physician Assistants
Physicians

GUIDELINE OBJECTIVE(S)

  • To facilitate optimum breastfeeding practices
  • To provide recommendations for the management of mastitis in lactating women

TARGET POPULATION

Lactating mothers with mastitis and their newborn infants

INTERVENTIONS AND PRACTICES CONSIDERED

Diagnosis/Evaluation

  1. Assessment of signs and symptoms
  2. Assessment of predisposing factors to the development of mastitis, resulting in milk stasis
  3. Laboratory investigations and other diagnostic procedures
    • Breastmilk culture and sensitivity testing
    • Diagnostic ultrasound for suspected abscess

Management/Treatment

  1. Effective milk removal
    • Frequent breastfeeding
    • Breast massage during feeding
    • Expressing milk after feeding
  2. Supportive measures
    • Rest
    • Adequate fluids
    • Adequate nutrition
  3. Pharmacologic management
    • Analgesia (ibuprofen)
    • Antibiotics (dicloxacillin, flucloxacillin, first generation, cephalosporins, cephalexin, clindamycin)
    • Treatment of methicillin-resistant Staphylococcus aureus (vancomycin, co-trimoxazole, rifampicin)
  4. Follow-up
  5. Management of complications
    • Support of patient to prevent early cessation of breastfeeding
    • Abscess (needle aspiration, antibiotics, surgical drainage where indicated)

Prevention

  1. Effective management of breast fullness and engorgement
  2. Prompt attention to signs of milk stasis
  3. Rest
  4. Hygiene

MAJOR OUTCOMES CONSIDERED

  • Complications of mastitis: early cessation of breastfeeding, abscess, infection
  • Effective milk removal
  • Symptom relief
  • Improved infant attachment to breast
  • Clinical response to treatment
  • Adverse effects of antibiotics

METHODOLOGY

METHODS USED TO COLLECT/SELECT EVIDENCE

Searches of Electronic Databases

DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

An initial search of relevant published articles written in English in the past 20 years in the fields of medicine, psychiatry, psychology, and basic biological science is undertaken for a particular topic. Once the articles are gathered, the papers are evaluated for scientific accuracy and significance.

NUMBER OF SOURCE DOCUMENTS

Not stated

METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Expert Consensus (Committee)
Weighting According to a Rating Scheme (Scheme Given)

RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Levels of Evidence

I Evidence obtained from at least one properly randomized controlled trial

II-1 Evidence obtained from well-designed controlled trials without randomization

II-2 Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group

II-3 Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence.

III Opinions of respected authorities, based on clinical experience, descriptive studies and case reports; or reports of expert committees

METHODS USED TO ANALYZE THE EVIDENCE

Review of Published Meta-Analyses
Systematic Review

DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

An expert panel is identified and appointed to develop a draft protocol using evidence based methodology. An annotated bibliography (literature review), including salient gaps in the literature, are submitted by the expert panel to the Protocol Committee.

METHODS USED TO FORMULATE THE RECOMMENDATIONS

Expert Consensus

DESCRIPTION OF METHODS USED TO FORMULATE THE RECOMMENDATIONS

Not stated

RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

COST ANALYSIS

A formal cost analysis was not performed and published cost analyses were not reviewed.

METHOD OF GUIDELINE VALIDATION

External Peer Review
Internal Peer Review

DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

Draft protocol is peer reviewed by individuals outside of lead author/expert panel, including specific review for international applicability. Protocol Committee's sub-group of international experts recommends appropriate international reviewers. Chair (co-chairs) institutes and facilitates process.

Reviews submitted to committee Chair (co-chairs).

Draft protocol is submitted to The Academy of Breastfeeding Medicine (ABM) Board for review and approval. Comments for revision will be accepted for three weeks following submission. Chair (co-chairs) and protocol author(s) amends protocol as needed.

Following all revisions, protocol has final review by original author(s) to make final suggestions and ascertain whether to maintain lead authorship.

Final protocol is submitted to the Board of Directors of ABM for approval.

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Definition and Diagnosis

The usual clinical definition of mastitis is a tender, hot, swollen, wedge-shaped area of breast associated with a temperature of 38.5°C or greater, chills, flu-like aching, and systemic illness. However, mastitis literally means, and is defined herein, as an inflammation of the breast; this may or may not involve a bacterial infection. Redness, pain, and heat may all be present when an area of the breast is engorged or "blocked"/"plugged," but an infection is not necessarily present. There appears to be a continuum from engorgement, non-infective mastitis, infective mastitis, to breast abscess.

Predisposing Factors

The following factors may predispose a lactating woman to the development of mastitis. Other than their being factors that result in milk stasis, the evidence for these associations is inconclusive:

  • Damaged nipple, especially if colonized with Staphylococcus (S.) aureus
  • Infrequent feedings or scheduled frequency or duration of feedings
  • Missing feedings
  • Poor attachment or weak or uncoordinated suckling leading to inefficient removal of milk
  • Illness in mother or baby
  • Oversupply of milk
  • Rapid weaning
  • Pressure on the breast (e.g., tight bra, car seatbelt)
  • White spot on nipple or blocked nipple pore or duct: milk blister, granular material, Candida
  • Maternal stress and fatigue
  • Maternal malnutrition (evidence of specific dietary risk factors in humans does not exist)

Investigations

Laboratory investigations and other diagnostic procedures are not routinely needed or performed for mastitis. The World Health Organization publication on mastitis suggests that breastmilk culture and sensitivity testing "should be undertaken if there is no response to antibiotics within two days, if the mastitis recurs, if it is hospital-acquired mastitis, when the patient is allergic to usual therapeutic antibiotics or in severe or unusual cases." Breastmilk culture may be obtained by collection of a hand-expressed midstream clean-catch sample into a sterile urine container (i.e., a small quantity of the initially expressed milk is discarded to avoid contamination of the sample with skin flora, and subsequent milk is expressed into the sterile container taking care not to touch the inside of the container). Cleansing the nipple prior to collection may further reduce skin contamination and false-positive culture results. Greater symptomatology has been associated with higher bacterial counts and/or pathogenic bacteria.

Management

Effective Milk Removal

Because milk stasis is often the initiating factor in mastitis, the most important management step is frequent and effective milk removal. Mothers should be encouraged to breastfeed more frequently, starting on the affected breast. If pain prohibits letdown, feeding may begin on the unaffected breast, switching to the affected breast as soon as letdown is achieved. Positioning the infant at the breast with the chin or nose pointing to the blockage will help drain the area. Massaging the breast during the feeding with an edible oil or nontoxic lubricant on the fingers may also be helpful. Massage should be directed from the blocked area moving toward the nipple. After the feeding, expressing milk by hand or pump may augment milk drainage and hasten resolution of the problem. There is no evidence of risk to the healthy, term infant of continuing breastfeeding. Women who are unable to continue breastfeeding should express the milk from breast by hand or pump, as sudden cessation of breastfeeding leads to a greater risk of abscess development than continuing to feed.

Supportive Measures

Rest, adequate fluids, and nutrition are essential measures. Practical help at home may be necessary for the mother to obtain adequate rest. Application of heat—for example, a shower or a hot pack—to the breast prior to feeding may help the milk flow. After feeding or expressing milk from the breasts, cold packs can be applied to the breast in order to reduce pain and edema.

Hospital admission should be considered in cases in which the woman is extremely ill and does not have supportive care at home. Rooming-in of the infant with the mother is mandatory so that breastfeeding can continue. In some hospitals, rooming-in may require hospital admission of the infant.

Pharmacologic Management

Although lactating women are often reluctant to take medications, women with mastitis should be encouraged to take appropriate medications as indicated.

Analgesia

Analgesia may help with the milk ejection reflex and should be encouraged. An anti-inflammatory agent such as ibuprofen may be more effective in reducing the symptoms relating to inflammation than a simple analgesic like paracetamol/acetaminophen. Ibuprofen is not detected in breastmilk following doses up to 1.6 g/day and is regarded as compatible with breastfeeding.

Antibiotics

If symptoms of mastitis are mild and have been present for less than 24 hours, conservative management (effective milk removal and supportive measures) may be sufficient. If symptoms are not improving within 12–24 hours or if the woman is acutely ill, antibiotics should be started. The most common pathogen in infective mastitis is penicillin-resistant S. aureus. Less commonly the organism is a Streptococcus or Escherichia coli. The preferred antibiotics are usually penicillinase-resistant penicillins, such as dicloxacillin or flucloxacillin, 500 mg four times a day. First-generation cephalosporins are also generally acceptable as first-line treatment, but may be less preferred because of their broader spectrum of coverage.

Cephalexin is usually safe in women with suspected penicillin allergy, but clindamycin is suggested for cases of severe penicillin hypersensitivity. Dicloxacillin appears to have a lower rate of adverse hepatic events than flucloxacillin. It tends to cause phlebitis if given intravenously, however, and so is preferable for oral treatment unless intravenous treatment is necessary.

Many authorities recommend a 10–14-day course of antibiotics; however, this has not been subject to controlled trials.

Resistance of S. aureus to penicillinase-resistant penicillins (methicillin-resistant S. aureus [MRSA], also referred to as oxacillin-resistant S. aureus (ORSA)] has been increasingly isolated in cases of mastitis and breast abscesses. Clinicians should be aware of the likelihood of this occurring in their community and should order a breastmilk culture and antibiotic sensitivities when women with mastitis are unresponsive to first-line treatment. Local resistance patterns for MRSA should be considered when choosing an antibiotic for such unresponsive cases while culture results are pending. Most strains of methicillin-resistant staphylococci are susceptible to vancomycin or co-trimoxazole and may be susceptible to rifampin. Of note, MRSA should be presumed to be resistant to treatment with macrolides and quinolones, regardless of susceptibility testing results. Furthermore, an MRSA isolate reported to be susceptible to clindamycin but resistant to erythromycin should undergo "D-testing," to confirm that it is in fact susceptible to the former.

As with other uses of antibiotics, repeated courses place women at increased risk for candidal breast and vaginal infections.

Follow-Up

Clinical response to the above management is typically rapid and dramatic. If the symptoms of mastitis fail to resolve within several days of appropriate management, including antibiotics, differential diagnoses should be considered. Further investigations may be required to confirm resistant bacteria, abscess formation, an underlying mass, or inflammatory or ductal carcinoma. More than two or three recurrences in the same location also warrant evaluation to rule out an underlying mass.

Complications

Early Cessation of Breastfeeding

Mastitis may produce overwhelming acute symptoms that prompt women to consider cessation of breastfeeding. Effective milk removal, however, is the most essential part of treatment. Acute cessation of breastfeeding may exacerbate the mastitis and result in an increased risk of abscess formation; therefore, effective treatment and support from health providers and family are important at this time. Mothers may need reassurance that the antibiotics they are taking are safe to use during breastfeeding.

Abscess

If a well-defined area of the breast remains hard, red, and tender despite appropriate management, then an abscess should be suspected. This occurs in about 3% of women with mastitis. The initial systemic symptoms and fever may have resolved. A diagnostic breast ultrasound will identify a collection of fluid. The collection can often be drained by needle aspiration, which itself can be diagnostic as well as therapeutic. Serial needle aspirations may be required. Ultrasound guidance for needle aspiration may be necessary in some cases. Milk should be sent for culture in the circumstance of an abscess. Consideration of resistant organisms should also be given depending on the incidence of resistant organisms in that particular environment. MRSA may be a community-acquired organism and has been reported to be a frequent pathogen in cases of breast abscess requiring hospitalization in some communities. Surgical drainage may be necessary if the abscess is very large or if there are multiple abscesses. After surgical drainage, breastfeeding on the affected breast should continue, even if a drain is present with the proviso that the infant's mouth does not come into direct contact with purulent drainage or infected tissue. A course of antibiotics should follow drainage of the abscess.

Candida Infection

Information on the etiology of burning nipple pain or radiating breast pain is evolving. Candidal infection has been associated with these symptoms. Diagnosis is difficult, as the nipples and breasts may look normal on examination, and milk culture may not be reliable. Careful evaluation for other etiologies for breast pain should be undertaken with particular attention to proper latch. When fissuring or trauma is present on the nipple, nipple swabs reveal that S. aureus may be present.

Prevention

Effective Management of Breast Fullness and Engorgement

  • Mothers should be helped to improve infants' attachment to the breast.
  • Feeds should not be restricted.
  • Mothers should be taught to hand-express if the breasts are too full for the infant to attach or the infant does not relieve breast fullness. A breast pump may also be used, if available, for these purposes, but all mothers should be knowledgeable in manual expression as the need for its use may arise unexpectedly.

Prompt Attention to Any Signs of Milk Stasis

  • Mothers should be taught to check their breasts for lumps, pain, or redness.
  • If the mother notices any signs of milk stasis, she needs to rest, increase the frequency of breastfeeding, apply heat to the breast prior to feedings, and massage any lumpy areas as described under "Effective milk removal."
  • Mothers should seek help from their health care provider if they are not improving within 24 hours.

Prompt Attention to Other Difficulties with Breastfeeding

Skilled help is needed for mothers with damaged nipples or an unsettled infant or those who believe that they have an insufficient milk supply.

Rest

As fatigue is often a precursor to mastitis, health professionals should encourage breastfeeding mothers to obtain adequate rest. It may be helpful for health care providers to remind family members that breastfeeding mothers may need more help and encourage mothers to ask for help as necessary.

Good Hygiene

Because S. aureus is a common commensal organism often present in hospitals and communities, the importance of good hand hygiene should not be overlooked. It is important for hospital staff, new mothers, and their families to practice good hand hygiene. Pump equipment may also be a source of contamination and should be washed thoroughly with soap and hot water after use.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence supporting the recommendations is not specifically stated.

The recommendations were based primarily on a comprehensive review of the existing literature. In cases where the literature does not appear conclusive, recommendations were based on the consensus opinion of the group of experts.

BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

POTENTIAL BENEFITS

  • Accurate diagnosis and appropriate management of mastitis and complications of mastitis in lactating women
  • Improved breastfeeding outcomes for mothers and infants

POTENTIAL HARMS

Dicloxacillin appears to have a lower rate of adverse hepatic events than flucloxacillin. It tends to cause phlebitis if given intravenously, however, and so is preferable for oral treatment unless intravenous treatment is necessary.

QUALIFYING STATEMENTS

QUALIFYING STATEMENTS

A central goal of the Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.

IMPLEMENTATION OF THE GUIDELINE

DESCRIPTION OF IMPLEMENTATION STRATEGY

An implementation strategy was not provided.

IMPLEMENTATION TOOLS

Foreign Language Translations

For information about availability, see the "Availability of Companion Documents" and "Patient Resources" fields below.

INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

IOM CARE NEED

Getting Better
Staying Healthy

IOM DOMAIN

Effectiveness
Patient-centeredness

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2008 May

GUIDELINE DEVELOPER(S)

Academy of Breastfeeding Medicine - Professional Association

SOURCE(S) OF FUNDING

Academy of Breastfeeding Medicine

A grant from the Maternal and Child Health Bureau, U.S. Department of Health and Human Services

GUIDELINE COMMITTEE

Academy of Breastfeeding Medicine Protocol Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee Members: Caroline J. Chantry, MD, FABM, Co-Chairperson; Cynthia R. Howard, MD, MPH, FABM, Co-Chairperson; Ruth A. Lawrence, MD, FABM; Kathleen A. Marinelli, MD, FABM, Co-Chairperson; Nancy G. Powers, MD, FABM

Contributor: *Lisa H. Amir, MBBS, MMed, PhD

*Lead author

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

None to report

GUIDELINE STATUS

This is the current release of the guideline.

Academy of Breastfeeding Medicine protocols expire five years from the date of publication. Evidence-based revisions are made within five years or sooner if there are significant changes in evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the Academy of Breastfeeding Medicine Web site.

Print copies: Available from the Academy of Breastfeeding Medicine, 140 Huguenot Street, 3rd floor, New Rochelle, New York 10801.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on March 19, 2009. The information was verified by the guideline developer on September 10, 2009.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo